Reply To: What is a Superficial Blood Clot

#402
The Bystander
Keymaster

    What happened with Jalen

    How the Injury Happened
    The Cause: Hurts was “cleated” (kicked) in the back of the leg during the Philadelphia Eagles Week 4 game against the Los Angeles Rams. Localized trauma like a blunt impact to the muscle can sometimes cause a blood clot to form in the nearby surface veins.

    The Timeline: He played through the discomfort during last week’s game against the Jacksonville Jaguars in London. An initial ultrasound out of caution revealed the superficial clot, but medical staff deemed it stable enough for him to safely play with mobility.

    Why He is Sidelined Now: A follow-up ultrasound on Wednesday night revealed movement in the small blood clot. Because the clot moved, the medical staff immediately sidelined him out of an abundance of caution while they determine the appropriate treatment.
    Medical Context for this Type of Clot
    While a standard superficial blood clot is usually low-risk and resolves on its own, the situation becomes medically complicated when it happens to a professional athlete in a contact sport:

    Risk of Deep Vein Thrombosis (DVT): The main risk of a moving superficial clot is that it could migrate or expand into the deep venous system. If it becomes a DVT, it could travel to the lungs, creating a dangerous and potentially life-threatening condition called a pulmonary embolism.

    The “No-Contact” Rule: If medical staff decide to put Hurts on standard blood thinners (anticoagulants) to manage the clot, he cannot play football. Playing a high-contact sport while taking blood thinners carries a massive risk of internal bleeding or severe bruising from hits.

    What happens if doctors decide to put Jalen Hurts on standard blood thinners (anticoagulants)
    If doctors put Jalen Hurts on standard blood thinners (anticoagulants), he will not be allowed to play football and could miss the rest of the 2026 NFL season.

    While anticoagulants are highly effective at preventing clots from growing or spreading to deeper veins, they create a major roadblock for professional athletes in contact sports:

    High Risk of Severe Internal Bleeding

    Blood thinners don’t dissolve an existing clot; they prevent new ones from forming and stop the existing one from expanding while the body naturally breaks it down. However, they drastically impair the blood’s ability to clot anywhere else. In a high-impact sport like football, a player taking blood thinners faces a massive, potentially life-threatening risk of uncontrollable internal bleeding or an intracranial hemorrhage (brain bleed) from standard hits.

    Sidelined for a Long Treatment Window

    Standard medical protocols for a clot requiring anticoagulation typically demand a treatment window lasting anywhere from 45 days to 3 months, and sometimes up to 6 months if the clot has spread to the deep veins. Because he cannot take physical contact while the medication is active in his system, a 3-to-6-month timeline would effectively end his season.

    Alternative Recovery Timelines

    If the Philadelphia Eagles medical team manages to avoid putting him on standard blood thinners, his timeline becomes much more favorable:

    No Blood Thinners: If the clot stabilizes and can be managed purely with rest, heat, elevation, and anti-inflammatories, he could return in a matter of weeks once the clot naturally resolves and the leg heals.

    Minor Surgery: If appropriate, a minor surgical procedure to remove the localized clot could be considered. The incision would take roughly 7 to 10 days to heal, potentially allowing for a much faster return to the field.

    Because the team is evaluating his ongoing serial ultrasound scans, Hurts’ return timeline is currently considered out indefinitely. In the meantime, backup quarterback Tanner McKee is slated to start for the Eagles.